Filed: 10/26/2022ACC: 0001104659-22-111588
📋 What this filing means
KPCB XV ASSOCIATES, LLC filed this quarterly 13F‑HR report disclosing 3 equity positions with a total reported market value of $35.8K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
3
Positions
$35.8K
Total AUM (reported)
2.72M
Total Shares
Allocation by class
COMMON STOCK$22.7K63.3%
CLASS A COMMON STOCK$13.1K36.7%
Portfolio Concentration
Top 3$35.8K100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 2.72M
Sole
Full voting authority
2.72M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole3
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings3
Rows:
Rapt Therapeutics, Inc.
SOLEShares648.53K
TypeSH
Market value$15.6K
43.54%
Sole
648.53K
Shared
0.00
None
0.00
Twilio Inc.
SOLEShares190.05K
TypeSH
Market value$13.1K
36.66%
Sole
190.05K
Shared
0.00
None
0.00
Atara Biotherapeutics, Inc.
SOLEShares1.88M
TypeSH
Market value$7.1K
19.79%
Sole
1.88M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Rapt Therapeutics, Inc.SOLE | Common Stock | 648.53K | SH | $15.6K 43.54% | 648.53K | 0.00 | 0.00 |
Twilio Inc.SOLE | Class A Common Stock | 190.05K | SH | $13.1K 36.66% | 190.05K | 0.00 | 0.00 |
Atara Biotherapeutics, Inc.SOLE | Common Stock | 1.88M | SH | $7.1K 19.79% | 1.88M | 0.00 | 0.00 |